Atossa Therapeutics Announces Expanded Research Agreement With Weill Cornell Medicine to Further Evaluate Synergy Between Antibody Drug Conjugates (Adcs) and (Z)-Endoxifen
Atossa Therapeutics宣布扩大与威尔康奈尔医药的研究协议,以进一步评估抗体药物偶联物(Adcs)和(Z)-恩多昔芬之间的协同作用
Atossa Therapeutics Announces Expanded Research Agreement With Weill Cornell Medicine to Further Evaluate Synergy Between Antibody Drug Conjugates (Adcs) and (Z)-Endoxifen
Atossa Therapeutics宣布扩大与威尔康奈尔医药的研究协议,以进一步评估抗体药物偶联物(Adcs)和(Z)-恩多昔芬之间的协同作用
使用浏览器的分享功能,分享给你的好友吧